An International, Multicenter, Prospective Registry on Post-traumatic Long Bones Defects
Condition(s) studied
Investigational drug(s) / intervention(s)
Any treatment that is used for a defect of any long bone: Any treatment that is used for a defect of any long bone. All treatments are based on individual clinician's judgement and the patient characteristics. The registry does not dictate any specific treatment.
Study summary
Long bone defect (LBD) is defined as a focalized loss of bone tissue in any long bone of the upper or lower extremity. Long bone defects are a complex problem, that may arise as a complication of many different pathologies, such as trauma, tumors or infection. Whereas post-traumatic defects are the largest group.
Reports estimate that there are almost 4 million bone grafting procedures worldwide per year. However, limb reconstruction in the context of a bony defect is challenging and up to date there is little evidence and treatment recommendations.
In a multi-national approach, the aim of this project is to set up an international, multicenter registry to gather information and details on prevalence or incidence, current treatments, complications and outcome.
Eligibility
Primary outcome measure(s)
- Baseline characteristics — Pre-operative
Demographics, medical history, comorbidity - Bone defect details — Pre-operative and/or intraoperative
* Affected bone * Localization: Proximal 1/3rd, middle 3rd, distal 1/3rd(for any bone) * Size (categorization according Karger classification; definition: a bone defect should be at least 2 cm (Karger Type II)) Type II: 2-5 cm Type III: 5-10 cm Type IV: \> 10 cm - Trauma assessment — Pre-operative and/or intraoperative
* Injury Severity Score (ISS): Grading for each item (points): No injury (0), Minor (1), Moderate (4), Serious (9), Severe (16), Critical (25), Unsurvivable (75) * Assessment: * Head and neck worst injury * Face worst injury * Chest worst injury * Abdomen worst injury * Extremity (including pelvis) worst injury * External worst injury * Gustilo \& Anderson classification for open fractures * Type I * Type II * Type IIIA * Type IIIB * Type IIIC * Tscherne classification for closed fracture and soft-tissue injuries * Grade 0 * Grade 1 * Grade 2 * Grade 3 - evaluate the bone defect in the context of previous interventions — Intraoperative
Number of previous interventions: \<2, \<4, \>4 - Surgical details & Intraoperative findings 1 — Intraoperative
* Procedure type: * One stage * Staged (e.g. Masquelet technique / distraction osteogenesis / bone transport) * Ilizarov * Bone quality (good, fair, poor) by surgeon's discretion * Soft tissue and vascularity (good, fair, poor) by surgeon's discretion * Contamination (yes/no) Specification: * Metal from a bullet * Metal from a pole * Other Metal * Wood * Soil * Others * Surgical time (min) * Stabilization technique: Internal device (extra- or intramedullary) / External device (For both, drop down menu will be used) - Surgical details & Intraoperative findings 2 — Intraoperative
* Bone grafting * Autografts * Allograft(s) * Other synthetics * If applicable - time to harvest graft (in minutes) * Graft enhancement yes / no * Demineralized bone matrix (DBM) * Bone morphogenetic protein (BMP) * Stem cells * Platelet rich plasma (PRP) * Other * Soft-tissue / vascular / microsurgical procedure yes / no * Skin graft * Local flap * Free flap * Additional treatment * Systemic antibiotic treatment yes / no * Local antibiotic treatment yes / no * Post-operative use of a negative pressure dressings (NPWT) or vacuum-assisted closure (VAC) system yes / no - Functional Outcome — 6 months follow-up / 12 months follow-up and/or 6 months after bone union (max 12 months)
\- Assessment of limb function and loss of length * Definition: anatomic shortening of the limb in comparison to the contralateral side * Assessment in cm * Any orthotic used to equalize leg length - Patient related outcome / Quality of life 1 — Screening / 6 months follow-up / 12 months follow-up and/or 6 months after bone union (max 18 months)
Patient-Reported Outcomes Measurement Information System (PROMIS) * Physical function: This item measures self-reported capability rather than actual performance. It includes the functioning of lower extremities (walking or mobility) as well as instrumental activities of daily living, such as running errands. We will use the short form 10b. * Physical function, upper extremity: This item measures activities that require use of the upper extremity including shoulder, arm, and hand activities. Examples include writing, using buttons, or opening containers. We will use the short form 7. * Pain Interference: This item assesses self-reported consequences of pain on relevant aspects of one's life. This includes the extent to which pain hinders engagement with social, cognitive, emotional, physical, and recreational activities. We will use the short form 8a. Short forms will be used in all sites possible (i.e. where the translation is available). - Patient related outcome / Quality of life 2 — Screening / 6 months follow-up / 12 months follow-up and/or 6 months after bone union (max 18 months)
EQ-5D-3L assessment (Five items, 3-point categorical scale) The EQ-5D-3L descriptive system comprises the following five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 3 levels: no problems, some problems, and extreme problems. o The EQ VAS records the patient's self-rated health on a vertical visual analogue scale where the endpoints are labelled 'Best imaginable health state' and 'Worst imaginable health state'. The VAS can be used as a quantitative measure of health outcome that reflects the patient's own judgement. - Radiological Outcome — Screening / / Intraoperative / 6 months follow-up / 12 months follow-up and/or 6 months after bone union (max 18 months)
Pre-operative/intraoperative * Deformity parameters (if applicable) * Nonunion classification: Hypertrophic, Oligotrophic, Atrophic Follow-up visits * Bone healing (based on the treating physician's judgement): Not healed / Partially healed / Mostly healed / Healed * Evaluation of the expansion of the bone defect: bone defect size * Time to healing: Date when full healing is achieved (to be calculated days from index surgery)
Trial sites (21)
| Facility | City | Region | Status |
|---|---|---|---|
| Cedar Sinai | Los Angeles | California | Recruiting |
| Sinai Hospital of Baltimore | Baltimore | Maryland | Recruiting |
| John Hunter Hospital | Newcastle | Australia | Recruiting |
| Hospital Municipal Miguel Couto Serviço de Ortopedia e Traumatologia | Rio de Janeiro | Brazil | Recruiting |
| Hospital Base Valdivia | Valdivia | Chile | Recruiting |
| Hospital Universitario de la Samaritana | Bogotá | Colombia | Suspended |
| Hospital Pablo Tobon Uribe | Medellín | Colombia | Recruiting |
| University Hospital Frankfurt | Frankfurt | Germany | Recruiting |
| Universitätsspital Gießen | Giessen | Germany | Recruiting |
| Universitätsklinikum Heidelberg (Unfallchirurgie) | Heidelberg | Germany | Terminated |
| Universitätsklinikum Münster (Klinik und Poliklinik für Unfall-, Hand- und Wiederherstellungschirurgie) | Münster | Germany | Recruiting |
| Krankenhaus Johanneum | Wildeshausen | Germany | Not Yet Recruiting |
| Paras HMRI Hospital Patna | Patna | India | Recruiting |
| Academisch Ziekenhuis Maastricht (Dept. of Surgery) | Maastricht | Netherlands | Recruiting |
| Radboud University Medical Center | Nijmegen | Netherlands | Recruiting |
| Tygerberg Hospital | Cape Town | South Africa | Not Yet Recruiting |
| Kyungpook National University Hospital (Orthopaedics) | Daegu | South Korea | Recruiting |
| Universitätsspital Zürich (Klinik für Traumatologie) | Zurich | Switzerland | Recruiting |
| Central Hospital of Border Guard Service of Ukraine | Kyiv | Ukraine | Not Yet Recruiting |
| Leeds General Infirmary University Hospital (Trauma & Orthopaedic Surgery) | Leeds | United Kingdom | Not Yet Recruiting |
| Hospital Universitario de Caracas | Caracas | Venezuela | Not Yet Recruiting |
More AO Innovation Translation Center trials in India
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT04112992 on ClinicalTrials.gov ↗ ← All trials in India